Fox Chase Researcher Henkel Valentine Recognized as an IMPACT Fellow by the National Postdoctoral Association

Dr. valentine
Henkel Valentine, PhD, was one of six postdoctoral researchers nationwide recently recognized as an IMPACT Fellow by the National Postdoctoral Association.

PHILADELPHIA (October 30, 2023) — Henkel Valentine, PhD, a postdoctoral fellow in the lab of Philip Abbosh, MD, PhD, in the Nuclear Dynamics and Cancer Research Program at Fox Chase Cancer Center, was one of six postdoctoral researchers nationwide recently recognized as an IMPACT Fellow by the National Postdoctoral Association.

The association is a charitable and educational nonprofit organization that works to improve the postdoctoral experience by supporting a culture of inclusive connection. The organization was formed in 2003 with the goal of effecting positive change for postdoctoral scholars.

“Being selected as a 2023-2024 IMPACT fellow is an honor, and I am proud to be a part of this year’s cohort,” said Valentine. “I intend to utilize the extensive resources and network allotted to IMPACT fellows to further my development as a cancer researcher and refine my scientific method.”

Valentine’s work involves using the gene editing tool CRISPR to develop mouse models of bladder cancer to replicate mutations commonly seen in bladder cancer patients. The model will be used to nominate new therapy options on which to base clinical trials for bladder cancer patients.

The IMPACT Fellowship Program was launched in 2021. It provides exceptional early-career researchers from under-represented communities with opportunities for professional and personal achievement.

During the 16-month program, fellows work with experts in their field, network with peers, and make mentoring connections that will help build their professional relationships. Fellows additionally use the knowledge, tools, and resources that they gain from the program to create and implement projects that benefit their home communities. These projects are discussed with peers during the program’s annual summit, where researchers receive valuable feedback from experts in the field.

“In STEM, particularly in fields like cancer research, there’s a significant lack of representation from the Black community,” Valentine said. “My IMPACT project aims to inspire and educate high school students of Black ancestry about the possibilities within STEM. We’ll achieve this by connecting them with professionals who share their background through career talks and interactions, demystifying scientific research, and sparking their passion for STEM.”

“We are thrilled to welcome this cohort of remarkable individuals who are not only striving to reach their full potential but committed to lift up one another along the way,” said Thomas P. Kimbis, JD, Executive Director and Chief Executive Officer of the National Postdoctoral Association. “By strengthening themselves through the IMPACT program, they position themselves as leaders within their fields, their communities, and our society.”

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427